AVITA Medical (RCEL) Cash & Current Investments (2018 - 2025)
AVITA Medical filings provide 8 years of Cash & Current Investments readings, the most recent being $18.2 million for Q4 2025.
- On a quarterly basis, Cash & Current Investments fell 49.32% to $18.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $18.2 million, a 49.32% decrease, with the full-year FY2025 number at $18.2 million, down 49.32% from a year prior.
- Cash & Current Investments hit $18.2 million in Q4 2025 for AVITA Medical, up from $16.2 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $115.1 million in Q1 2021 to a low of $14.1 million in Q2 2025.
- Median Cash & Current Investments over the past 5 years was $69.2 million (2023), compared with a mean of $63.0 million.
- Biggest five-year swings in Cash & Current Investments: surged 50.25% in 2021 and later tumbled 73.96% in 2025.
- AVITA Medical's Cash & Current Investments stood at $85.4 million in 2021, then decreased by 7.05% to $79.3 million in 2022, then dropped by 1.26% to $78.3 million in 2023, then crashed by 54.19% to $35.9 million in 2024, then crashed by 49.32% to $18.2 million in 2025.
- The last three reported values for Cash & Current Investments were $18.2 million (Q4 2025), $16.2 million (Q3 2025), and $14.1 million (Q2 2025) per Business Quant data.